Loteprednol Etabonate
29 interactions 90 cited referencesRead the full Loteprednol Etabonate drug information page
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Loteprednol Etabonate Aspirin Acuprin® An increased risk of salicylism subsequent to withdrawal of corticosteroids Details Loteprednol Etabonate Bemiparin Increased risk of bleeding Details Loteprednol Etabonate Carbamazepine Carbatrol Reduced corticosteroids exposure and reduced efficacy of corticosteroids Details Loteprednol Etabonate Cosyntropin False elevations of plasma cortisol levels Details Loteprednol Etabonate Ethinyl Estradiol Increased corticosteroid exposure Details Loteprednol Etabonate Fosphenytoin Cerebyx Reduced corticosteroid exposure Details Loteprednol Etabonate Insulin Aspart, Recombinant Fiasp Reduced blood glucose lowering effect of insulin Details Loteprednol Etabonate Insulin Glargine, Recombinant Basaglar Reduced blood glucose lowering effect of insulin Details Loteprednol Etabonate Insulin Icodec-Abae Awiqli Reduced efficacy of insulin icodec-abae Details Loteprednol Etabonate Lutetium Lu 177 Dotatate Decreased lutetium Lu 177 dotatate efficacy Details Loteprednol Etabonate Macimorelin False-positive or false-negative adult growth hormone deficiency diagnosis Details Loteprednol Etabonate Nadroparin Increased risk of bleeding Details Loteprednol Etabonate Phenytoin Dilantin Reduced corticosteroid exposure Details Loteprednol Etabonate Rabies Vaccine Imovax An inadequate immunological response to the vaccine, an increased risk of altered immunocompetence and reduced immune response to... Details Loteprednol Etabonate Relacorilant Lifyorli Reduced relacorilant exposure and reduced efficacy of relacorilant, reduced glucocorticoids exposure and reduced efficacy of gluco... Details Loteprednol Etabonate Sargramostim Leukine Increased myeloproliferative effects of sargramostim Details Loteprednol Etabonate Somatrogon-Ghla Reduced serum cortisol exposure, an increased risk of central (secondary) hypoadrenalism and attenuated growth-promoting effects o... Details Loteprednol Etabonate Upadacitinib Rinvoq Increased risk of gastrointestinal perforations DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist